| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.68B | +152.8% | +123.4% |
| Cost of Revenue | $11.88B | +161.2% | +137.3% |
| Gross Profit | $798.6M | +70.9% | +19.2% |
| R&D Expense | $180.8M | +4.3% | +14.2% |
| SG&A Expense | $70.4M | +10.3% | +10.7% |
| Operating Income | $474.3M | +160.2% | +28.7% |
| Pre-tax Income | $500.2M | +139.8% | +33.4% |
| Income Tax | $99.2M | +146.9% | +74.0% |
| Net Income | $400.6M | +138.0% | +24.9% |
| EPS (Basic) | $0.67 | +139.3% | +24.1% |
| EPS (Diluted) | $0.60 | +130.8% | +17.6% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.09B | -2.5% | +186.1% |
| Accounts Receivable | $11.00B | +335.8% | +259.7% |
| Inventory | $10.60B | +84.9% | +194.6% |
| Current Assets | $26.12B | +106.3% | +201.4% |
| Total Assets | $28.00B | +94.6% | +187.8% |
| Current Liabilities | $15.40B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$941.4M | -2.6% | — |
| Capital Expenditures | $53.5M | +65.8% | — |
| Investing Cash Flow | -$78.5M | -143.2% | — |
| Financing Cash Flow | $47.5M | +354.5% | — |
| Free Cash Flow | -$994.9M | -4.8% | — |
| +1033.9% |
| Total Liabilities | $21.01B | +167.2% | +502.0% |
| Stockholders' Equity | $6.99B | +7.2% | +12.1% |